NEW DELHI: It’s a potent cocktail of rivalries involving pharma companies and NGOs. It has now emerged that Aids Healthcare Foundation (AHF), the US-based NGO that accused Cipla of over pricing anti-AIDS drug, Viraday, in India is part funded by American anti-AIDS drug maker Gilead and the NGO’s treasurer is a senior Gilead executive.
This is largely the reason why foreign and Indian NGOs such as Medicine Sans Frontier (MSF), Delhi Network of Positive People (DNP+), Indian Network of Positive People (INP+), Sahara and others refused to be part of AHF’s anti-Cipla campaign.
Cipla had refused Gilead’s offer to sell the latter’s anti-AIDS drug Viread under a licensing agreement. Cipla is also the only Indian company opposing Gilead’s patent application for its blockbuster anti-HIV drug Viread in India. The hearing for the patent case of Viread is due in October.
read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment